Neurotoxicity associated with chimeric antigen receptor T-cell therapy.
Wronski M, Wesselingh R, Kazzi C, Seery N, Ko K, Li J, Tan TH, Simpson T, Abbott C, Fleming S, Inam S, Tam CS, Wong SM, O'Brien T, van der Walt A, Spencer A, Butzkueven H, Monif M.
Wronski M, et al.
J Neuroimmunol. 2025 Oct 15;407:578717. doi: 10.1016/j.jneuroim.2025.578717. Epub 2025 Aug 9.
J Neuroimmunol. 2025.
PMID: 40812205
Free article.
Review.
Chimeric antigen receptor T cell (CAR-T) therapy involves reengineering patient-derived or donor-derived T cells to express a synthetic CAR that can recognise specific cell-surface antigens, independently of major histocompatibility complex molecules. ...Alth …
Chimeric antigen receptor T cell (CAR-T) therapy involves reengineering patient-derived or donor-derived T cells to exp …